Our overall aim is to advance understanding of the molecular basis for optimal fetal – infant growth and placental function. Application of new tools, analytics and imaging technologies could provide novel insights to unsolved problems in MNCH.
Our overall aim is to advance the systems immunology tool box to address global health questions using innovative technologies, novel analytical tools and by learning novel basic immunology.
To encourage and foster collaboration toward solutions for global health challenges, we are opening an opportunity for collaborative pilot awards between Stanford University and the Ragon Institute.
The Wu Tsai Neurosciences Institute Interdisciplinary Scholar Awards provide funding to extraordinary postdoctoral scientists at Stanford University engaging in highly interdisciplinary research in the neurosciences broadly defined.
Stanford ChEM-H is soliciting collaborative seed grant proposals from the Stanford community of postdoctoral researchers for exploratory projects that align with the Institute’s mission.
The Spectrum MedTech Pilot Program funds projects involving medical devices and mobile technologies used for (1) therapeutic applications and (2) device-based patient-specific (or POC) diagnostic applications.
The Spectrum SPADA Pilot Program funds projects with a goal of diagnosing and/or predicting the onset, course, worsening, or complications of disease, and prolonging health.